Progression-Free but No Overall Survival Benefit for Adult Patients with Bevacizumab Therapy for the Treatment of Newly Diagnosed Glioblastoma: A Systematic Review and Meta-Analysis.

导出 OA

翻译打印收藏纠错

第一作者： Nagham,Kaka

第一单位： School of Medicine, National University of Ireland Galway, H91 TK33 Galway, Ireland. N.Kaka1@nuigalway.ie.

作者： Nagham,Kaka ^[1] ; Karim,Hafazalla ^[2] ; Haider,Samawi ^[3] ; Andrew,Simpkin ^[4] ; James,Perry ^[5] ; Arjun,Sahgal ^[6] ; Sunit,Das ^[7]

作者单位： School of Medicine, National University of Ireland Galway, H91 TK33 Galway, Ireland. N.Kaka1@nuigalway.ie. ^[1] Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA 19107, USA. karim.hafazalla@jefferson.edu.;Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, ON M5B 1A6, Canada. karim.hafazalla@jefferson.edu. ^[2] Division of Hematology/Oncology, St. Michael's Hospital, Toronto, ON M5B 1W8, Canada. SamawiH@smh.ca. ^[3] School of Mathematics, Statistics and Applied Mathematics, National University of Ireland, H91 TK33 Galway, Ireland. andrew.simpkin@insight-centre.org. ^[4] Department of Neurology, Sunnybrook Hospital, Toronto, ON M4N 3M5, Canada. james.perry@sunnybrook.ca. ^[5] Department of Radiation Oncology, Sunnybrook Hospital, Toronto, ON M4N 3M5, Canada. Arjun.Sahgal@sunnybrook.ca. ^[6] Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, ON M5B 1A6, Canada. sunit.das@utoronto.ca.;Division of Neurosurgery, University of Toronto, Toronto, ON M5B 1W8, Canada. sunit.das@utoronto.ca. ^[7]

关键词 bevacizumab glioblastoma meta-analysis

DOI 10.3390/cancers11111723

PMID 31689995

发布时间 2020-09-28

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Cancers

2019年11卷11期

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Progression-Free but No Overall Survival Benefit for Adult Patients with Bevacizumab Therapy for the Treatment of Newly Diagnosed Glioblastoma: A Systematic Review and Meta-Analysis.

Cancers

相似文献

Cancers

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Progression-Free but No Overall Survival Benefit for Adult Patients with Bevacizumab Therapy for the Treatment of Newly Diagnosed Glioblastoma: A Systematic Review and Meta-Analysis.

Cancers

相似文献

Cancers

相关期刊

检索历史清除